Pharmaceutical Business review

D3 Pharma, Encap to advance Plenachol licensing program

Plenachol is proprietary high-dose oral vitamin D3 product for the treatment of vitamin D deficiency and insufficiency.

The patented liquid-filled capsule formulation was developed in conjunction with Encap and is available at three dose-strengths 20,000, 40,000 and 100,000 international units.

Plenachol, which is free from animal derived excipients and peanut constituents, will continue to be made available as a Specials product during the pre-license phase through Encap.